• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT STENT SYSTEM; VASCULAR AND BILIARY STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT STENT SYSTEM; VASCULAR AND BILIARY STENT Back to Search Results
Model Number EX071203CS
Device Problems Fracture (1260); Difficult to Remove (1528); Misfire (2532)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 09/23/2019
Event Type  Injury  
Manufacturer Narrative
The lot number for the device was provided.The device history records are currently under review.The device has been returned for evaluation.The investigation is currently underway.(expiry date 11/2020).
 
Event Description
It was reported that during a stent placement procedure in the iliac vein, the stent allegedly partially deployed and fractured in half.It was further reported that there was difficult retracting the delivery system from the patient but a segment of the fractured stent was removed without incident.An attempt was made to retrieve the remaining fragment was unsuccessful.Reportedly, another stent along with additional balloon dilatation was used to apose the remaining stent fragment to the vessel wall and cover the lesion to complete the procedure.The patient was reportedly stable at the conclusion of the procedure.
 
Manufacturer Narrative
H10: manufacturing review: review of manufacturing records was not performed, as no additional complaint has been reported for this lot.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: based on the investigation of the returned sample a stent fracture could be confirmed.The catheter sample was returned in fully activated condition and a failure/ damage on the delivery system could not be found.The stent was returned as a separate piece in fractured condition.Although a deployment issue could not be found on the returned delivery system it was assumed that a partial stent deployment led to stent fracture as reported.Therefore, the investigation will be closed as confirmed for partial stent deployment.Based on the information available and the evaluation of the sample returned, a definite root cause could not be determined.Labeling review: in reviewing the relevant vascular labeling for this product, it was found that the instructions for use (ifu) sufficiently address the potential factors.The ifu state: 'visually inspect the distal end of the stent system to ensure that the stent is contained within the sheath.Do not use if the stent is partially deployed.' holding and handling of the system throughout the deployment procedure was found sufficiently described.Regarding pta the ifu state: 'predilation of the lesion should be performed using standard techniques.While maintaining site access with a guidewire, remove the balloon catheter from the patient.' the ifu further state: 'if excessive force is felt during stent deployment, do not force the stent system.Remove the stent system as possible, and replace with a new unit.The intended stent placement in the iliac vein represents an off label use of the device.Based on the ifu supplied with this product, the lifestent xl vascular stent system is intended to improve luminal diameter (.) in the native superficial femoral artery (sfa) and popliteal artery (.).
 
Event Description
It was reported that during a stent placement procedure in the iliac vein, the stent allegedly partially deployed and fractured in half.It was further reported that there was difficult retracting the delivery system from the patient but a segment of the fractured stent was removed without incident.An attempt was made to retrieve the remaining fragment was unsuccessful.Reportedly, another stent along with additional balloon dilatation was used to apose the remaining stent fragment to the vessel wall and cover the lesion to complete the procedure.The patient was reportedly stable at the conclusion of the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT STENT SYSTEM
Type of Device
VASCULAR AND BILIARY STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key9215224
MDR Text Key163059053
Report Number9681442-2019-00190
Device Sequence Number1
Product Code NIP
UDI-Device Identifier04049519001319
UDI-Public(01)04049519001319
Combination Product (y/n)N
PMA/PMN Number
P070014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberEX071203CS
Device Catalogue NumberEX071203CS
Device Lot NumberANCY1517
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/17/2019
Initial Date Manufacturer Received 09/24/2019
Initial Date FDA Received10/21/2019
Supplement Dates Manufacturer Received12/03/2019
Supplement Dates FDA Received12/04/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Weight109
-
-